• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1400087 注射用重组人源化抗HER2单抗-MMAE偶联剂 disitamab vedotin Lyophilized Biological Products(1) New Drug Application 2014-09-18 烟台荣昌生物工程有限公司 RemeGen Co Ltd Certificate Issued 2015-10-13 view